Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
3,750 Shares in Campbell Soup (NASDAQ:CPB) Bought by Morse Asset Management Inc
Morse Asset Management Inc bought a new position in Campbell Soup (NASDAQ:CPB – Free Report) during the 3rd quarter, according...
Reynders McVeigh Capital Management LLC Takes $279,000 Position in The Progressive Co. (NYSE:PGR)
Reynders McVeigh Capital Management LLC bought a new position in The Progressive Co. (NYSE:PGR – Free Report) during the third...
Vericel (NASDAQ:VCEL) Upgraded to “Strong-Buy” at Stephens
Stephens upgraded shares of Vericel (NASDAQ:VCEL – Free Report) to a strong-buy rating in a research note released on Monday...
SYM FINANCIAL Corp Grows Holdings in SPDR Gold Shares (NYSEARCA:GLD)
SYM FINANCIAL Corp increased its position in shares of SPDR Gold Shares (NYSEARCA:GLD – Free Report) by 26.2% during the...
Atlassian (NASDAQ:TEAM) Price Target Raised to $350.00
Atlassian (NASDAQ:TEAM – Get Free Report) had its price target hoisted by Wells Fargo & Company from $300.00 to $350.00...
Sphera Funds Management LTD. Invests $6.66 Million in Biohaven Ltd. (NYSE:BHVN)
Sphera Funds Management LTD. bought a new stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) in the third...